Syneron Candela Goes Private In $400M Deal With Apax

Irvine-based aesthetic medical device developer Syneron Medical announced late Monday evening that it has become a private company, in a $400M go-private deal with Apax Partners. According to Syneron Medical, funds advised by Apax Partners paid $11.00 per share in cash for the company. The deal had originally announced on April 3rd. As part of the go-private deal, Syneron said that Geoffrey Crouse has been appointed CEO of the company, and also has joined its board. Crouse is the former CEO of Cord Blood Registry, and was COO of Immucor, among other experience. Syneron Medical makes fat reduction devices used in the aesthetic medicine market.